Skip to main content

Table 2 Comparison of daily doses of clarithromycin (CAM), rifampicin (RFP), ethambutol (EB), and levofloxacin (LVFX) for pulmonary Mycobacterium avium complex patients between the control and the LVFX group

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Drug Daily dose (mg) Control group (n = 57) LVFX group (n = 18)
CAM 400 1 1
600 1 2
800 55 15
RFP 300 11 2
450 46 16
EB 500 29 6
750 26 7
1000 2 2
LVFX 300 - 7
  375 - 2
  500 - 9
  1. Values express as number of patients. There was no significant difference for each dosage between both groups
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us